Anavex Ebit vs Total Other Income Expense Net Analysis

AVXL Stock

USD 9.11 0.09 1.00%

Anavex Life financial indicator trend analysis is way more than just evaluating Anavex Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anavex Life Sciences is a good investment. Please check the relationship between Anavex Life Ebit and its Total Other Income Expense Net accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Ebit vs Total Other Income Expense Net

Ebit vs Total Other Income Expense Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anavex Life Sciences Ebit account and Total Other Income Expense Net. At this time, the significance of the direction appears to have pay attention.

The correlation between Anavex Life's Ebit and Total Other Income Expense Net is -0.87. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of Anavex Life Sciences, assuming nothing else is changed. The correlation between historical values of Anavex Life's Ebit and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Anavex Life Sciences are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Ebit i.e., Anavex Life's Ebit and Total Other Income Expense Net go up and down completely randomly.

Correlation Coefficient

-0.87

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Ebit

Total Other Income Expense Net

Most indicators from Anavex Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 47.1 M this year, although Enterprise Value Over EBITDA will most likely fall to (6.30).

	2021	2022	2023	2024 (projected)
Tax Provision	358.5K	7K	8.1K	7.6K
Interest Income	947.0K	6.5M	7.5M	7.9M

Tax Provision Interest Income

Anavex Life fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Long Term Debt Total	Other Current Assets	Short Term Debt	Property Plant And Equipment Net	Current Deferred Revenue	Non Current Assets Total	Property Plant And Equipment Gross	Non Current Liabilities Total	Net Receivables	Net Tangible Assets	Other Assets
Total Assets		0.93	0.96	1.0	-0.98	-0.93	1.0	1.0	0.9	0.91	0.98	0.93	1.0	0.91	0.78	-0.22	0.05	-0.36	-0.08	0.58	-0.26	-0.08	0.85	0.64	1.0	0.32
Other Current Liab	0.93		0.96	0.93	-0.88	-0.91	0.93	0.93	0.89	0.91	0.96	0.91	0.93	0.91	0.79	-0.27	0.01	-0.27	-0.1	0.71	-0.11	-0.1	0.8	0.42	0.93	0.2
Total Current Liabilities	0.96	0.96		0.96	-0.93	-0.96	0.96	0.96	0.95	0.96	0.99	0.96	0.96	0.95	0.85	-0.28	0.14	-0.32	-0.11	0.69	-0.27	-0.11	0.85	0.63	0.96	0.22
Total Stockholder Equity	1.0	0.93	0.96		-0.98	-0.93	1.0	1.0	0.89	0.91	0.98	0.93	1.0	0.9	0.78	-0.24	0.04	-0.37	-0.09	0.56	-0.26	-0.09	0.84	0.64	1.0	0.33
Net Debt	-0.98	-0.88	-0.93	-0.98		0.93	-0.98	-0.98	-0.87	-0.88	-0.95	-0.89	-0.98	-0.87	-0.76	0.25	-0.04	0.36	0.11	-0.55	0.24	0.11	-0.79	-0.68	-0.98	-0.4
Retained Earnings	-0.93	-0.91	-0.96	-0.93	0.93		-0.93	-0.93	-0.94	-0.97	-0.97	-0.93	-0.93	-0.95	-0.87	0.25	-0.24	0.38	0.08	-0.71	0.22	0.08	-0.8	-0.61	-0.93	-0.33
Cash	1.0	0.93	0.96	1.0	-0.98	-0.93		1.0	0.9	0.91	0.98	0.93	1.0	0.91	0.78	-0.22	0.04	-0.35	-0.08	0.57	-0.26	-0.08	0.85	0.62	1.0	0.33
Cash And Short Term Investments	1.0	0.93	0.96	1.0	-0.98	-0.93	1.0		0.9	0.91	0.98	0.93	1.0	0.91	0.78	-0.22	0.04	-0.35	-0.08	0.57	-0.26	-0.08	0.85	0.62	1.0	0.33
Common Stock Total Equity	0.9	0.89	0.95	0.89	-0.87	-0.94	0.9	0.9		0.93	0.94	0.96	0.9	1.0	0.88	-0.08	0.21	-0.21	0.12	0.83	-0.21	0.12	0.86	0.62	0.89	0.26
Common Stock Shares Outstanding	0.91	0.91	0.96	0.91	-0.88	-0.97	0.91	0.91	0.93		0.96	0.9	0.91	0.94	0.93	-0.32	0.29	-0.48	-0.12	0.71	-0.08	-0.12	0.74	0.61	0.91	0.27
Other Stockholder Equity	0.98	0.96	0.99	0.98	-0.95	-0.97	0.98	0.98	0.94	0.96		0.96	0.98	0.95	0.84	-0.24	0.14	-0.37	-0.07	0.66	-0.25	-0.07	0.86	0.58	0.98	0.28
Total Liab	0.93	0.91	0.96	0.93	-0.89	-0.93	0.93	0.93	0.96	0.9	0.96		0.93	0.97	0.79	0.02	0.09	-0.22	0.1	0.71	-0.33	0.1	0.96	0.59	0.93	0.2
Total Current Assets	1.0	0.93	0.96	1.0	-0.98	-0.93	1.0	1.0	0.9	0.91	0.98	0.93		0.91	0.78	-0.22	0.05	-0.36	-0.08	0.58	-0.26	-0.08	0.85	0.64	1.0	0.32
Common Stock	0.91	0.91	0.95	0.9	-0.87	-0.95	0.91	0.91	1.0	0.94	0.95	0.97	0.91		0.87	-0.08	0.2	-0.21	0.11	0.82	-0.22	0.11	0.87	0.6	0.9	0.24
Accounts Payable	0.78	0.79	0.85	0.78	-0.76	-0.87	0.78	0.78	0.88	0.93	0.84	0.79	0.78	0.87		-0.32	0.32	-0.52	0.05	0.76	0.08	0.05	0.61	0.62	0.78	0.13
Short Long Term Debt Total	-0.22	-0.27	-0.28	-0.24	0.25	0.25	-0.22	-0.22	-0.08	-0.32	-0.24	0.02	-0.22	-0.08	-0.32		-0.17	0.37	0.59	-0.06	-0.13	0.59	0.21	-0.2	-0.24	-0.08
Other Current Assets	0.05	0.01	0.14	0.04	-0.04	-0.24	0.04	0.04	0.21	0.29	0.14	0.09	0.05	0.2	0.32	-0.17		-0.25	-0.09	0.29	0.02	-0.09	-0.01	0.16	0.05	-0.07
Short Term Debt	-0.36	-0.27	-0.32	-0.37	0.36	0.38	-0.35	-0.35	-0.21	-0.48	-0.37	-0.22	-0.36	-0.21	-0.52	0.37	-0.25		0.2	0.09	-0.18	0.2	-0.12	-0.28	-0.36	-0.1
Property Plant And Equipment Net	-0.08	-0.1	-0.11	-0.09	0.11	0.08	-0.08	-0.08	0.12	-0.12	-0.07	0.1	-0.08	0.11	0.05	0.59	-0.09	0.2		0.18	-0.07	1.0	0.19	-0.11	-0.09	-0.05
Current Deferred Revenue	0.58	0.71	0.69	0.56	-0.55	-0.71	0.57	0.57	0.83	0.71	0.66	0.71	0.58	0.82	0.76	-0.06	0.29	0.09	0.18		0.04	0.18	0.55	0.34	0.57	0.07
Non Current Assets Total	-0.26	-0.11	-0.27	-0.26	0.24	0.22	-0.26	-0.26	-0.21	-0.08	-0.25	-0.33	-0.26	-0.22	0.08	-0.13	0.02	-0.18	-0.07	0.04		-0.07	-0.47	-0.24	-0.25	-0.16
Property Plant And Equipment Gross	-0.08	-0.1	-0.11	-0.09	0.11	0.08	-0.08	-0.08	0.12	-0.12	-0.07	0.1	-0.08	0.11	0.05	0.59	-0.09	0.2	1.0	0.18	-0.07		0.19	-0.11	-0.09	-0.05
Non Current Liabilities Total	0.85	0.8	0.85	0.84	-0.79	-0.8	0.85	0.85	0.86	0.74	0.86	0.96	0.85	0.87	0.61	0.21	-0.01	-0.12	0.19	0.55	-0.47	0.19		0.52	0.84	0.1
Net Receivables	0.64	0.42	0.63	0.64	-0.68	-0.61	0.62	0.62	0.62	0.61	0.58	0.59	0.64	0.6	0.62	-0.2	0.16	-0.28	-0.11	0.34	-0.24	-0.11	0.52		0.64	0.14
Net Tangible Assets	1.0	0.93	0.96	1.0	-0.98	-0.93	1.0	1.0	0.89	0.91	0.98	0.93	1.0	0.9	0.78	-0.24	0.05	-0.36	-0.09	0.57	-0.25	-0.09	0.84	0.64		0.33
Other Assets	0.32	0.2	0.22	0.33	-0.4	-0.33	0.33	0.33	0.26	0.27	0.28	0.2	0.32	0.24	0.13	-0.08	-0.07	-0.1	-0.05	0.07	-0.16	-0.05	0.1	0.14	0.33

Click cells to compare fundamentals

Anavex Life Account Relationship Matchups

Anavex Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	34.5M	161.6M	152.7M	154.4M	177.5M	186.4M
Other Current Liab	3.3M	5.6M	6.4M	8.2M	9.4M	9.9M
Total Current Liabilities	7.3M	10.8M	10.2M	12.5M	14.4M	15.1M
Total Stockholder Equity	27.2M	150.8M	142.5M	141.9M	163.1M	171.3M
Net Debt	(29.2M)	(152.1M)	(149.2M)	(151.0M)	(135.9M)	(129.1M)
Retained Earnings	(159.7M)	(197.6M)	(245.6M)	(293.1M)	(263.8M)	(250.6M)
Cash	29.2M	152.1M	149.2M	151.0M	173.7M	182.4M
Cash And Short Term Investments	29.2M	152.1M	149.2M	151.0M	173.7M	182.4M
Common Stock Total Equity	52.7K	62.0K	75.9K	77.9K	89.6K	94.1K
Common Stock Shares Outstanding	58.2M	69.8M	76.9M	79.8M	91.8M	96.3M
Liabilities And Stockholders Equity	34.5M	161.6M	152.7M	154.4M	177.5M	186.4M
Other Stockholder Equity	186.9M	348.3M	388.0M	434.8M	500.1M	525.1M
Total Liab	7.3M	10.8M	10.2M	12.5M	14.4M	15.1M
Total Current Assets	34.5M	161.6M	152.7M	154.4M	177.5M	186.4M
Common Stock	62.0K	75.9K	77.9K	82K	94.3K	99.0K
Accounts Payable	4.0M	4.7M	3.8M	4.3M	5.0M	5.2M
Other Current Assets	443.8K	371.9K	354K	653K	751.0K	496.3K
Non Current Liabilities Total	3.3M	5.6M	4.3M	7.3M	8.4M	8.8M
Net Receivables	4.8M	9.1M	3.2M	2.7M	3.1M	2.1M
Net Tangible Assets	27.2M	150.8M	142.5M	141.9M	163.1M	171.3M
Retained Earnings Total Equity	(133.4M)	(159.7M)	(197.6M)	(245.6M)	(221.0M)	(210.0M)
Capital Surpluse	153.6M	186.9M	348.3M	388.0M	446.2M	468.5M
Net Invested Capital	27.2M	150.8M	142.5M	141.9M	163.1M	82.9M
Net Working Capital	27.2M	150.8M	142.5M	141.9M	163.1M	82.9M
Capital Stock	62.0K	75.9K	77.9K	82K	94.3K	72.7K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:

How To Invest In Anavex

Details

Is Anavex Stock a good investment?

Details

What is Anavex Life's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.51)

Return On Assets

(0.20)

Return On Equity

(0.30)

The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Anavex Ebit vs Total Other Income Expense Net Analysis

Ebit vs Total Other Income Expense Net

Ebit vs Total Other Income Expense Net Correlation Analysis

Correlation Coefficient

Ebit

Total Other Income Expense Net

Anavex Life fundamental ratios Correlations

Anavex Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Anavex Life fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity

Net Tangible Assets	- 0.98	Net Debt
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Net Debt	- 0.98	Total Stockholder Equity
Net Debt	- 0.98	Total Assets